000 01146 a2200325 4500
005 20250511130852.0
264 0 _c19790425
008 197904s 0 0 eng d
022 _a0300-7995
024 7 _a10.1185/03007997809110214
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMilligan, M P
245 0 0 _aBromocriptine in the treatment of secondary amenorrhoea and ovarian dysfunction in hyper- and normo-prolactinaemic patients.
_h[electronic resource]
260 _bCurrent medical research and opinion
_c1978
300 _a734-8 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article
650 0 4 _aAmenorrhea
_xblood
650 0 4 _aBromocriptine
_xadverse effects
650 0 4 _aClinical Trials as Topic
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aOvarian Diseases
_xblood
650 0 4 _aProlactin
_xblood
700 1 _aMoore, D M
700 1 _aSingh, M M
700 1 _aBuckingham, M S
700 1 _aElstein, M
773 0 _tCurrent medical research and opinion
_gvol. 5
_gno. 9
_gp. 734-8
856 4 0 _uhttps://doi.org/10.1185/03007997809110214
_zAvailable from publisher's website
999 _c389626
_d389626